| __timestamp | ADMA Biologics, Inc. | Celldex Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 20622000 |
| Thursday, January 1, 2015 | 6745968 | 33837000 |
| Friday, January 1, 2016 | 8494742 | 35979000 |
| Sunday, January 1, 2017 | 18092835 | 25003000 |
| Monday, January 1, 2018 | 22502922 | 19269000 |
| Tuesday, January 1, 2019 | 25910757 | 15426000 |
| Wednesday, January 1, 2020 | 35050817 | 14456000 |
| Friday, January 1, 2021 | 42896889 | 20488000 |
| Saturday, January 1, 2022 | 52458024 | 27195000 |
| Sunday, January 1, 2023 | 59020000 | 30914000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of ADMA Biologics, Inc. and Celldex Therapeutics, Inc. from 2014 to 2023. Over this period, ADMA Biologics saw a staggering increase of over 1,100% in their SG&A expenses, reflecting their aggressive growth strategy. In contrast, Celldex Therapeutics experienced a more modest rise of about 50%, indicating a more conservative approach.
By 2023, ADMA Biologics' SG&A expenses were nearly double those of Celldex, highlighting their significant investment in scaling operations. This divergence in financial strategy underscores the varied paths companies can take in the biotech sector. Understanding these trends provides valuable insights into how these companies prioritize spending to drive innovation and market presence.
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Celldex Therapeutics, Inc.
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Halozyme Therapeutics, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Madrigal Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs ADMA Biologics, Inc.
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Mesoblast Limited
Bausch Health Companies Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
MannKind Corporation and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Travere Therapeutics, Inc. and Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. or Evotec SE: Who Manages SG&A Costs Better?